Oxcarbazepine Tablet, Film Coated
Product Images NDC 60290-069

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 60290-069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Umedica Laboratories Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Oxcarbazepine Tabs Usp 150mg 100s Bottle Label)

Oxcarbazepine Tablets, USP 150 mg film-coated tablets label including storage instructions, dosage note to see package insert, and caution to keep out of reach of children. Label shows 100 tablets per container, manufactured by Umedica Laboratories Pvt. Ltd. in India and distributed by Umedica Laboratories USA Inc. in New Jersey. NDC 60290-067-01 and a QR code with GTIN and placeholder text for serial number, expiration date, and lot number are also visible.*

FDA Label Image

Image Description (Oxcarbazepine Tabs Usp 300mg 100s Bottle Label)

Label for Oxcarbazepine Tablets, USP 300 mg, film-coated oral tablets. The label includes storage instructions, manufacturer Umedica Laboratories Pvt. Ltd. in India, distributor Umedica Laboratories USA Inc., and package size of 100 tablets. It features an NDC barcode, product identifiers, and a patient medication guide link.*

FDA Label Image

Image Description (Oxcarbazepine Tabs Usp 600mg 100s Bottle Label)

Label for Oxcarbazepine Tablets, USP 600 mg film-coated oral tablets. The label indicates 100 tablets per container, manufactured by Umedica Laboratories Pvt. Ltd., India, and distributed by Umedica Laboratories USA Inc., Parsippany, NJ. The label includes storage instructions and a barcode, along with a GTIN and placeholder fields for serial number, expiration date, and lot number.*

FDA Label Image

"image Description" (Oxcarbazepine Tabs Usp Graph 1)

A Kaplan-Meier survival curve comparing exit rates over time for Oxcarbazepine treatment versus placebo. The x-axis represents days on trial from Day 2 to Day 11, and the y-axis shows exit rates from 0 to 1. The Oxcarbazepine group is represented by a solid line, while the placebo group has a dashed line, indicating higher exit rates in the placebo group. The graph includes a log-rank test p-value of 0.0001.*

FDA Label Image

"image Description" (Oxcarbazepine Tabs Usp Graph 2)

A Kaplan-Meier survival curve chart depicting seizure rate over days from first dose to first seizure comparing treatment groups Oxcarbazepine and placebo. The x-axis shows days up to 140, and the y-axis represents seizure rate from 0.0 to 1.0. The chart includes a log-rank test p-value of 0.046.*

FDA Label Image

"image Description" (Oxcarbazepine Tabs Usp Graph 3)

A Kaplan-Meier survival curve chart depicting the exit rate over time in days for two treatment groups labeled 'HIGH' and 'LOW'. The y-axis shows the exit rate from 0.0 to 1.0, while the x-axis represents time to exit in days up to 130 days. The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*

FDA Label Image

"image Description" (Oxcarbazepine Tabs Usp Graph 4)

A Kaplan-Meier survival curve showing exit rates over time (days) for two treatment groups labeled HIGH and LOW. The chart includes a log-rank test p-value of 0.0001, indicating statistical comparison between the groups. The x-axis represents time to exit in days, and the y-axis represents exit rates.*

FDA Label Image

"image Description" (Oxcarbazepine Tabs Usp Structure)

Chemical structure of Oxcarbazepine shown as a molecular diagram with rings and functional groups, including a ketone and amide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.